Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mesoblast Ltd ADR (NQ: MESO )

2.800 -0.150 (-5.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 23, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 103,309
Open 2.840
Bid (Size) 2.280 (2)
Ask (Size) 3.050 (16)
Prev. Close 2.950
Today's Range 2.750 - 2.880
52wk Range 2.140 - 7.275
Shares Outstanding 650,454,551
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022
Upgrades 
Via Benzinga
Short Volatility Alert: Mesoblast Limited
On Wednesday, shares of Mesoblast Limited (NASDAQ: MESO) experienced volatile short activity. After the activity, the stock price went up +2.77% to $3.34. The overall sentiment for MESO has been... 
Via Benzinga

Performance

YTD
-43.78%
-43.78%
1 Month
-2.78%
-2.78%
3 Month
+18.14%
+18.14%
6 Month
-33.49%
-33.49%
1 Year
-55.48%
-55.48%

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
R&D Efforts for Alzheimer’s Therapies on the Rise with over 120 Drugs in Development
Via FinancialNewsMedia
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Single Dose Of Mesoblast's Cell Therapy Shows Durable Reduction In Back Pain
Via Benzinga
87 Biggest Movers From Yesterday
Via Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
FDA's Office Agrees On 12-Month Reduction In Pain As Primary Endpoint For Mesoblast's Back Pain Study
Via Benzinga
Alzheimer’s Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases
Via FinancialNewsMedia
Topics Death
Exposures Death
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
Via Benzinga
46 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
36 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
50 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Mesoblast Shares Are Falling
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Mesoblast's Heart Failure Candidate Shows Treatment Benefit In High-Risk Patients
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.